RxDoctor Payments Data

Donna Ford, APRN

Adult Health · New Britain, CTNPI 1609064054

Payments from drug & device makers

$1,762in general payments, 2019–2025

Across 77 payments — averaging $22.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$413
  • E.r. Squibb & Sons, L.L.C.$294
  • LEO Pharma Inc.$210
  • Galderma Laboratories, L.p.$155
  • Incyte Corporation$107
  • Sanofi$87
  • plus $496 from 14 others

What the payments were for

  • Food & beverage$1,762100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,762 in reported general payments places this provider in the 75th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut

Medicare billing

Part B allowed, 2024
$32,821
Medicare patients
113
Services billed
642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SkyriziRisankizumab-Rzaa14$281,417
Humira PenAdalimumab25$201,143
Cosentyx (2 Syringes)Secukinumab11$80,191
OtezlaApremilast11$62,565
Dupixent PenDupilumab13$48,646
JubliaEfinaconazole12$13,979
Calcipotriene20$2,709
Clobetasol Propionate64$2,309
Ketoconazole88$1,319
Tretinoin13$1,242
Doxycycline Monohydrate47$1,211
Clindamycin Phosphate30$1,036
Metronidazole16$825
Betamethasone Dipropionate11$497
Minocycline Hcl11$354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSkyrizi$413$281,41714 claims
NovartisCosentyx (2 Syringes)$62$80,19111 claims
AmgenOtezla$34$62,56511 claims
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$24$13,97912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 418 adult health providers in Connecticut.

Other adult health in New Britain

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →